Agoracom Blog

My Search for the Healthiest Baby Formula – SPONSOR: Else Nutrition $BABY.ca $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:12 PM on Thursday, May 7th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY)The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q2 2020 with International agreements in Q3. Learn More

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

My Search for the Healthiest Baby Formula

by Robin Barrie Kaiden, MS, RD, CDN

Robin Barrie Kaiden, MS, RD, CDN is renowned for helping people of all ages embrace a healthier lifestyle through nutrition and fitness counseling.  As a Licensed Registered Dietitian and Personal Trainer, her smart and sensible approach to pediatrics, weight loss, sports nutrition, allergies, cardiovascular health, pre/post natal, and other areas of clinical and lifestyle nutrition has resonated with hundreds of people across the United States. Robin received her B.S. and M.S. degrees in Nutrition and Exercise Science from Cornell and Columbia Universities.

A Personal Note from this Pediatric Registered Dietitian and Mom

When I began working as a Registered Dietitian in Pediatric Nutrition over 15 years ago, we, of course, were taught, and shared with patients, that breast milk was the best, healthiest option for feeding babies.  When that wasn’t possible, sufficient, or babies were being weaned, I knew that there were a variety of infant and toddler formulas available. We could recommend:

  1. Pre-term infant formula:  higher calories and minerals for infants born early
  2. Standard term infant formula:  intact milk protein
  3. Gentle/sensitive formulas: whey protein in milk partially broken down
  4. Soy-based formulas:  for those with milk intolerance, noting that over 50% of infants who don’t tolerate dairy, also do not tolerate soy protein
  5. Hydrolyzed formulas:  proteins are mostly, but not completely broken down
  6. Elemental formulas:  proteins completely broken down for severe milk allergies

At this point in my career, I did not study the ingredients of each, but rather selected the best option available to best aid in tolerance, intake and growth for the child.  There always seemed to be one that worked well…..at least well enough. The biggest problem with the hydrolyzed and elemental formulas was that they smelled and tasted terrible, and babies often refused to drink them.

Over 8 years ago, when I was pregnant with my first baby, I began to examine the healthiest baby formula options more in depth.   I discovered that not much had changed in this industry, except that there were a couple of organic options. After discussing with a colleague, I decided on a formula.  When my son was less than a week old, this product was recalled due to high arsenic levels. Plus, it seemed to upset his stomach. When my baby nurse suggested a non-organic, but “gentle” formula, I (reluctantly) agreed.  I disliked that it had corn syrup (processed inflammatory sugar) as one of the main ingredients, but I was a new mom, overwhelmed, and figured she had so much experience and knew what she was talking about. Plus, my pediatrician agreed as well.  A few weeks later, I just went back to the only other organic option on the market, and my son seemed to tolerate it well enough. It was the best I could find at that time. 

When it came time to find the healthiest baby formula for my second child, almost 2.5 years later, I become aware that there were some European products that had better ingredients.  However, it was pretty difficult and expensive to get these in the U.S. back then. I took comfort in the fact that my baby would be able to get great nutrition in the form of real food within about 4-5 months, and wean off formula totally at 1 year.  But all I could think was that I would love to create a new healthy baby formula myself. Why hadn’t someone come up with a better alternative yet? Aren’t the infant and toddler stages the most important as they are developing and growing so rapidly? Why wouldn’t everyone want offer the best possible nutrients to this group, if/when/after breast milk was not an option.

My children are now in elementary school and the infant/toddler formula industry is still, in my opinion extremely limited.  I was thrilled to hear about Else Nutrition, and flattered to consult on their timely products. Formulation of plant-based products is way overdue.   In the wake of a huge movement towards plant-based and plant-forward diets, due to increased research and interest, Else is a wonderful product to support infant and toddler Nutrition.  Read on to learn about all of its positive attributes.

Benefits of Else Plant-Based Formula Alternative

Choose Else Nutrition because it is:

  1. Organic:  This means that the USDA (United States Department of Agriculture) has determined that the ingredients in this healthy baby formula are free of genetically modified organisms (GMOs), fungicides, herbicides, and pesticides.   Organic practices result in enhanced soil and water quality and, in general, more overall sustainable farming (1).  Translation:  Organic foods are beneficial for our environment.  Research has shown that organic produce is more nutritious:  It has higher levels of antioxidants and lower levels of toxic metals (such as Cadmium).   Increased exposure to pesticides has been shown to increase risk for ADHD, Parkinson’s disease, diabetes, and some cancers (2).  The effects of chemicals used in conventional farming may be more detrimental to the small developing brains and bodies of babies/children than to those of adults. 
  2.  Glyphosate-free:  Yes, the USDA Organic Label is important, however, it may not be enough today.  It ensures that crops are GMO-free, but this doesn’t mean a product is 100% free of pesticides.   Glyphosate is an herbicide (pesticide) that is carcinogenic (can cause cancer). Final organic food products are often NOT tested.  The USDA does not check for glyphosate residue. The buckwheat and almond sources in Else formulas are glyphosate-free.
  3. Made from clean ingredients:  Else formulas are simple and pure.  Almonds, buckwheat, and tapioca make up about 92% of the product.  The ingredient list is short and easy to understand. There are no added unhealthy oils, inflammatory sugar/corn syrups, artificial sweeteners, or gums/stabilizers/fillers than can upset small bellies.   For moms looking to supplement breast milk or wean their children after 1 year of age, it may seem that there are many dairy-free milk substitutes and products on the market today; however, none are quite right for little developing brains and bodies.  They are not nearly as nutritionally dense as breast milk (or full-fat dairy milk). They may be low-fat, low in protein, and other nutrients, and often contain added sugars and fillers as mentioned above. They are simply NOT appropriate, and in fact, unhealthy as a foundation for a toddler’s diet.  This is especially true for vegans and/or those who truly cannot tolerate dairy protein.
  4. Pleasantly mild in flavor:  When babies are weaned off breast milk and/or need a supplement or substitute for human or cow’s milk, they are more likely to accept a drink/formula that tastes great (they are indeed little humans).  Other formulas may not be as mild.  In fact, the hydrolyzed/elemental formulas have a reputation of smelling bad and tasting worse.  Such formulas may be indicated for little ones with dairy allergies and intolerances, and digested well; however, if the child will not drink due to the smell/taste, this can be an issue.  
  5. Vegan/Plant-based:  In case you haven’t noticed, there has been a huge buzz surrounding “plant-based” and “plant-forward” nutrition.  This is not new news to us health professionals. We have always known that a variety of fruits, vegetables, whole grains, legumes, fiber, and healthy fats were integral for good health.  The research is finally catching up. We now know that our microbiome (the collection of microorganisms-bacteria, fungi, viruses-that live in/on the human body) can benefit our health, especially immunity, aging, digestion, metabolism, mood and mental health.   We can best benefit our microbiome by consuming a diet rich in a variety of plant-based foods. Why not start our little ones on such a diet with a plant-based formula?! Research shows that children on a predominantly plant-based diet have increased microbial biodiversity and richness (3).  
  6. Dairy-Free and Soy-free:  Infants and toddlers with food allergies, intolerances, and/or sensitivities simply cannot tolerate many formulas on the market today.  The incidence of food allergies is on the rise in children and adults. According to the Mayo Clinic: “Food allergy is an immune system reaction that occurs soon after eating a certain food. Even a tiny amount of the allergy-causing food can trigger signs and symptoms such as digestive problems, hives or swollen airways. In some people, a food allergy can cause severe symptoms or even a life-threatening reaction known as anaphylaxis.”(4)  Cow’s milk is the most allergenic food for in children in the U.S. (followed by peanuts, eggs and soy).  Most of the formulas on the market are based on cow’s milk.  

Else’s products can be tolerated by children with dairy and soy allergies and sensitivities.  Anaphylaxis due to almond or buckwheat allergy is very rare (<1% and 1% of anaphylaxis cases in children respectively) with numbers well below egg, wheat, fish, goat/sheep’s milk, lentils, cashew, and peanut.

Also, just as an update and reminder about almonds:  recent research demonstrates that delaying introduction of potential allergenic foods (wheat, dairy, eggs, fish and nuts) may actually increase the risk of food allergies and/ or eczema.  The American Academy of Asthma, Allergy and Immunology (AAAAI) now recommends they be introduced without delay, and not wait up to 1-3 years of age, as advised in the past (5).

  1. Nutrient composition matches breast milk:  We all know that breast milk is the gold standard for feeding infants.  However, if and when it is not possible, and/or a child requires supplementation or is being weaned, Else Nutrition provides a formula with nutrients that match that of breast milk.  The macronutrients (carbohydrates, fat, and protein) and micronutrients (vitamins and minerals) are the same in Else formula-even though Else is a vegan product. Moms and caregivers can be confident that their babies are being nourished while they slowly learn how to eat solids.   
  2. Created and supported by the best team:  These formulas were created by leaders in the infant and toddler nutrition industry.   Their formulation and ingredients have been tested, approved, and supported by pediatricians, gastroenterologists, registered dietitians, and MOMS and DADS!  

References:

  1. https://www.ams.usda.gov/sites/default/files/media/Organic%20Practices%20Factsheet.pdf
  2. https://www.ncbi.nlm.nih.gov/pubmed/29073935
  3. https://www.ncbi.nlm.nih.gov/pubmed/20679230
  4. https://www.mayoclinic.org/diseases-conditions/food-allergy/symptoms-causes/syc-20355095
  5. https://www.jaci-inpractice.org/article/S2213-2198(12)00014-1/fulltext

Source: https://elsenutrition.com/blogs/news/my-search-for-the-healthiest-baby-formula

Online education now a new normal for govt, #Edtech platforms – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 10:39 AM on Thursday, May 7th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

Online education now a new normal for govt, edtech platforms

  • As millions of kids take online school classes from home globally including in India, government along with private education sector have a great responsibility to offer online e-Learning to more than 60 million college students and 1.5 billion school students worldwide, experts said on Thursday

Private colleges in India which were already offering online education for last two decades now have a massive surge in e-Learning demand to meet.

“e-Learning or online education is the new normal. In future, we will see the proliferation of information technology tools and gadgets, post-COVID-19. But internet and broadband will remain an issue,” said Professor NK Goyal, Vice Chairman, ITU APT India and former adviser of Gujarat Technological University.

If e-Learning apps like BYJU’s and Khan academy are targeting schools, others like Adda24x7 are offering specialised coaching for entrance exams like IIT and JEE.

Robust connectivity is undoubtedly critical for the success of e-Learning.

According to Rajan S Mathews, DG, the Cellular Operators Association of India (COAI), post COVID-19, there will be a surge in online education by schools and colleges in the country.

“The telecom industry is fully prepared with 99.9 per cent network capacity. The telecom companies have taken appropriate measures to meet the surge in traffic due to online education and other online activities using telecom infrastructure,” said Mathews.

Union Human Resources and Development (HRD) Minister Ramesh Pokhriyal Nishank recently said that the government is offering a slew of educational applications and platforms for both school and higher education institutes.

In addition to teachers, Nishank urged parents and students to make maximum use of online education to ensure their academic continuity is maintained.

The World University of Design (WUD) claims that it has collected materials for online learning across its courses during the last one year.

“WUD is using technology-enabled AI, supervision technologies and video conferencing and other tools to enable virtual learning. This includes a mix of online platforms for sharing files, conducting meetings and lectures in association with online services iamp; resource providers like Coursera, Bloomsbury, EBSCO etc. as partners in its strategy,” said Dr Sanjay Gupta, Vice Chancellor, World University of Design (WUD).

Source: https://www.newkerala.com/news/2020/80541.htm

#AI can distinguish between bots and humans based on #Twitter activity – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 10:08 AM on Thursday, May 7th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI can distinguish between bots and humans based on Twitter activity

  • Artificial intelligence is being used to spot the difference between human users and fake accounts on Twitter
  • Researchers found that human users replied between four and five times more often to other tweets than bots did
  • Real users gradually become more interactive, with the fraction of replies increasing over the course of an hour-long session of Twitter use

By Donna Lu

Artificial intelligence is being used to spot the difference between human users and fake accounts on Twitter.

Emilio Ferrara at the University of Southern California and his colleagues have trained an AI to detect bots on Twitter based on differences in patterns of activity between real and fake accounts.

The team analysed two separate data sets of Twitter users, which had been classified either manually or by a pre-existing algorithm as either bot or human.

The manually verified data set consisted of 8.4 million tweets from 3500 human accounts, and 3.4 million tweets from 5000 bots.

The researchers found that human users replied between four and five times more often to other tweets than bots did. Real users gradually become more interactive, with the fraction of replies increasing over the course of an hour-long session of Twitter use.

The length of tweets by human users also decreased as sessions progressed. “The amount of information that is exchanged diminishes,” says Ferrara. He believes that the change may result from a cognitive depletion over time, in which people become less likely to expend mental effort composing original content.

Bots, on the other hand, show no changes in their interactivity or the length of information they tweet over time.

Read more: https://www.newscientist.com/article/2241327-ai-can-distinguish-between-bots-and-humans-based-on-twitter-activity/#ixzz6LlMIFlYe

Esports Entertainment Group $GMBL.ca Signs Binding LOI to Acquire Online Sportsbook and Casino Operator Argyll Entertainment $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM-JC at 7:01 AM on Thursday, May 7th, 2020
  • Signed a binding Letter of Intent to acquire LHE Enterprises Ltd, the holding company of online sportsbook and casino operator Argyll Entertainment AG and its operating support subsidiaries
  • Argyll has established itself as a fast growing and innovative gaming company within the UK and Irish market
  • “With Argyll already generating around $12 million in revenue annually, this acquisition will have a major positive impact for our company,” commented Grant Johnson, CEO of Esports Entertainment Group.

BIRKIRKARA, Malta, May 07, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, signed a binding Letter of Intent (LOI) to acquire LHE Enterprises Ltd, the holding company of  online sportsbook and casino operator Argyll Entertainment AG and its operating support subsidiaries (”Argyll”).

Since launching its flagship brand, www.sportnation.bet, in the summer of 2017, Argyll has established itself as a fast growing and innovative gaming company within the UK and Irish market leveraging the expertise of its 40 strong staff in marketing, technology, risk management, and regulation to offer its customers an entertaining, safe and secure online gaming experience, an award winning rewards program, and access to exclusive and proprietary sports and gaming content.

“With Argyll already generating around $12 million in revenue annually, this acquisition will have a major positive impact for our company,” commented Grant Johnson, CEO of Esports Entertainment Group. “In the current global environment of COVID-19 there has been a surge of interest in online gaming to fill the void left by traditional sports and other activities. Argyll’s established footprint and revenue base, combined with our strong cash position from our successful April capital raise combined with our esports betting platform, places Esports Entertainment in a great position to capitalize on this evolving opportunity.”

Argyll, incorporated in Switzerland, with operational support services in London, UK and Malta, is licensed and regulated by the UK Gambling Commission under licence no. 000-045143-R-323955-001 and the Irish Revenue Commissioners under licence reference no. 1014456 to operate online sportsbook and casino sites in the UK and Ireland, respectively.

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg.  In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

Gratomic $GRAT.ca Granted a Comprehensive Mining Licence for Base and Rare Metals, Industrial Minerals and Precious Metals $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca #TODAQ $NMI.ca

Posted by AGORACOM at 9:54 AM on Wednesday, May 6th, 2020
http://blog.agoracom.com/wp-content/uploads/2019/09/GRAT-square2.png
  • Securing the mining licence is a critical step towards moving the Aukam Mine into commercial production
  • Gratomic can now produce a concentrate of up to 98% Cg
  • A PEA on the Aukam Processing plant to be undertaken
  • Diamond drilling will resume at Aukam Graphite mine

TORONTO, ON / ACCESSWIRE / May 6, 2020 / Gratomic Inc. (“GRAT” or the “Company”) (TSXV:GRAT)(FRANKFURT:CB81)(WKN:A143MR) is pleased to announce, further to its Press Release dated March 26, 2020, that it has received confirmation from the Ministry of Mines and Energy of Namibia that the Minister has issued Mining Licence 215 (ML215) for the Company’s Aukam Graphite Property in Namibia. The Licence covers Base and Rare Metals, Industrial Minerals and Precious Metals. The Licence area falls within the proximity of the Aukam Processing Plant and the Graphite bearing shear zone for a total of 5002 hectares (5002 ha). Securing the mining licence is a critical step towards moving the Aukam Mine into commercial production.

The Company has completed 8 months of pilot testing on historically mined product and conducted an internal study on the efficiency of the pilot processing facility on this material. Through rigorous testing and adjustments to the plant, Gratomic can now produce a concentrate of up to 98% Cg. Management has subsequently decided to build a 20 000 tonne per annum processing plant. To date, 90% of construction is complete. Upon completion of the remaining 10%, the Company will initially start processing material from historical workings left at the surface when the mine last operated in 1974.

The Company has recently appointed Dr. Ian Flint to complete a preliminary economic assessment on the Aukam Processing plant. The study, its recommendations, and their subsequent implementation, will ensure the scale up of the existing pilot plant to a commercial scale processing facility that will provide the desired concentrate grades and production rates.

With respect to site exploration, in the coming months diamond drilling will resume at Aukam Graphite. The drilling will be conducted utilizing Company owned drilling equipment, focusing on areas proximal to graphite mineralization, depicted by previous diamond drilling, underground excavation and surface outcrop sampling. The drill targeting will be systematic with the expectation of producing an NI 43-101 resource estimate.

Arno Brand, President and CEO of the Company stated that “we are thrilled to receive the official mining licence for the Aukam Graphite Mine in Namibia. This is a monumental milestone for Gratomic, which took an extensive amount of effort to accomplish. Once the funding is secured, Gratomic will be able to move into the commercialization phase of development.”

Risk Factors

No mineral resources, let alone mineral reserves demonstrating economic viability and technical feasibility, have been delineated on the Aukam Property. The Company is not in a position to demonstrate or disclose any capital and/or operating costs that may be associated with the processing plant.

The Company advises that it has not based its production decision on even the existence of mineral resources let alone on a feasibility study of mineral reserves, demonstrating economic and technical viability, and, as a result, there may be an increased uncertainty of achieving any particular level of recovery of minerals or the cost of such recovery, including increased risks associated with developing a commercially mineable deposit.

Historically, such projects have a much higher risk of economic and technical failure. There is no guarantee that production will begin as anticipated or at all or that anticipated production costs will be achieved.

Failure to commence production would have a material adverse impact on the Company’s ability to generate revenue and cash flow to fund operations. Failure to achieve the anticipated production costs would have a material adverse impact on the Company’s cash flow and future profitability.

Steve Gray, P. Geo. has reviewed and approved the scientific and technical information in this press release and is the Company’s “Qualified Person” as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About Gratomic Inc.

Gratomic is an advanced materials company focused on mine to market commercialization of graphite products most notably high value graphene-based components for a range of mass market products. We have a Joint Venture collaboration with Perpetuus Carbon Technology, a leading European manufacturer of graphenes, to use Aukam graphite to manufacture graphene products for commercialization on an industrial scale. The Company is listed on the TSX Venture Exchange under the symbol GRAT.

For more information: visit the website at www.gratomic.ca or contact:

Arno Brand at [email protected] or 416 561-4095

Eyecarrot $EYC.ca #Zoom Video Conferencing Integration Supporting 20,000 Vision Performance Professionals Running Remote Binovi Pro Patient Care and Enrolling $EYPT $KALA $ZM

Posted by AGORACOM-JC at 9:07 AM on Wednesday, May 6th, 2020
Eyecarrot | LinkedIn
  • Integrated Zoom (NASDAQ:ZM) video conferencing into the Binovi Training Live initiative
  • Using the real-time capabilities of Zoom conferencing to connect with its network of approximately 20,000 industry professionals,
  • The company is conducting training on Binovi Pro and Binovi Coach applications, including an active customer success Q&A discussion

Toronto, New York – May 6th, 2020 – Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR), a leader in human performance neurovision software and hardware, is pleased to announce that it has integrated Zoom (NASDAQ:ZM) video conferencing into the Binovi Training Live initiative. Using the real-time capabilities of Zoom conferencing to connect with its network of approximately 20,000 industry professionals, the company is conducting training on Binovi Pro and Binovi Coach applications, including an active customer success Q&A discussion.

Zoom meetings provide live moderated question-and-answer sessions supported by simple registration to the Binovi Platform. Binovi enhances the active management of vision training patients within a diverse client community of neurovision specialists.

“We are forging forward with Zoom integration and have created a tremendous amount of value for our relationships using our Binovi Pro, Binovi Coach, and Binovi Academy resources. With the spread of COVID-19, governments, learning institutions, and businesses are facing a huge paradigm shift to a remote work, training, and eLearning culture. This shift has created an increase in demand for resources to continue operating as close to “status quo” which will lead to a greater adoption of our platform amongst care providers. We are happy to have built a platform that was designed for supporting patients and athletes remotely,” stated Adam Cegielski, Eyecarrot CEO.

With the global coronavirus pandemic disrupting all large gatherings, demand for remote training is surging, which will undoubtedly drive awareness and adoption of the company’s webinar conferencing and remote training platform. Many global companies including Microsoft (NASDAQ: MSFT), Google, Amazon (NASDAQ: AMZN) and Salesforce have enforced work-from-home policies amid the spread of COVID-19. Enforced social distancing protocols have also increased demand for Eyecarrot’s software as optometry clinics, sports vision specialists, and related industry conferences have suspended traditional services, with employees adopting a work-from-home routine.

“By leveraging Zoom’s video conferencing platform, we’re able to extend our presence beyond our usual face-to-face meetings and demonstrate the value and power of the Binovi Platform to prospective users, new users, and existing users, in an effective manner. We plan on further integrating Zoom’s technology into our own as we move forward,” commented Sam Mithani, Eyecarrot CTO.

Recent Eyecarrot News in 2020:

Eyecarrot Sports Vision Partnership with Eli Wilson Goaltending Redefines How 50,000 Aspiring Goalies See the Game

Eyecarrot Innovations Corp. to Acquire ConnectMe Lead Monetization SAAS

Eyecarrot Encourages Clinics to Work Remotely with Binovi Pro Patient Care

Eyecarrot Featured in BTV-Business Television Video Article Exploring Companies Using Innovation to Drive Success

Eyecarrot Announces Vision Training Partnership Agreement with the Dallas Stars

In Depth – Using Binovi for Remote Care

For additional information, please visit https://www.eyecarrot.com/investors

About Eyecarrot Innovations Corp

Eyecarrot is a human performance technology company that has developed Binovi , a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Adam Cegielski

Founder | CEO

Sam Mithani PhD
CTO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

North Bud Farms $NBUD.ca Provides Update on U.S. and Quebec Subsidiaries $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:16 AM on Wednesday, May 6th, 2020
  • Quebec government recently announced that, effective May 11, 2020, it will begin easing its Covid-19 related restrictions on business operations in the province
  • Subject to the implementation of said easing measures, NORTHBUD intends to commence scaling its Quebec production accordingly

TORONTO, May 06, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to provide shareholders with the following corporate update:

Quebec Cultivation Facility

Easing of Covid-19 Restrictions

The Quebec government recently announced that, effective May 11, 2020, it will begin easing its Covid-19 related restrictions on business operations in the province. Subject to the implementation of said easing measures, NORTHBUD intends to commence scaling its Quebec production accordingly, and has advised its suppliers that it will be ready to receive starting materials quickly upon implementation of the easing measures.

Outdoor Cultivation Licence Application Status

With respect to the Company’s previously disclosed intention to apply for an amendment to its existing cultivation licence at its Quebec facility to allow for outdoor cultivation, the Company is pleased to announce that it has submitted to Health Canada all required materials and documentation for the aforementioned licence amendment, and it now awaits the issuance of a licence to allow for a proposed 1 million square feet of outdoor production.  “With the underlying fundamentals and low-cost capacity of our Quebec facility, especially with the expected addition of outdoor capacity, we believe this facility has the potential to add value and we continue to explore collaborations with companies who have established distribution channels and who are relying on the volatile wholesale market to fulfill their cultivation needs,” said Ryan Brown, the Company’s Executive Chairman and Interim CEO.  â€œManagement is encouraged by the amount of interest being shown for potential collaborations and will update shareholders when there are any material developments on this front.”

To date the Company has signed a letter of intent to supply product to a licensed distributor, and is actively negotiating additional supply contracts with other parties.  Securing these supply agreements is expected to provide the Company with further insight into revenue potential and operating capital required for its Quebec facility.  While the Company has initiated operations at its Quebec facility, currently the Company does not have sufficient working capital and financial resources to commercialize the full capacity of its Quebec facility.

Furthermore, in light of current market conditions, the Company is exploring options to extend its cash runway to further operations, including with respect to staffing decisions.

U.S. Operations

The Company also announces that it has signed a non-binding letter of intent to sell all the shares of its U.S. subsidiary, Bonfire Brands USA, Inc. (“BBUSA”), to an entity controlled by Mr. Justin Braune, the President of BBUSA.  The proposed transaction is expected to close on or before May 15, 2020, and would constitute a related-party transaction as defined in Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The proposed transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the shares of BBUSA proposed to be sold to the acquiror does not exceed 25% of the Company’s market capitalization.  This determination is based upon the fact that the value of the net assets of BBUSA is negligible as the assets acquired were, and continue to be, highly leveraged.  In light of the current market conditions, it is no longer economically viable for the Company to continue to try to sustain and develop these assets.

Under the terms of the proposed transaction, which remain subject to the negotiation of a definitive share purchase agreement and customary closing conditions and approvals, the acquiring party will become responsible for and guarantee all of BBUSA’s past and future liabilities and capital requirements, including all of the outstanding intercompany debts owed to NORTHBUD.  The acquiror will also retain rights to the name “Bonfire Brands” and the Company will no longer proceed with the change of name and symbol that was approved at the last shareholder meeting.  Final terms of the proposed transaction will be announced upon the signing of the definitive agreement.  

“The structure of this proposed transaction represents the furtherance of the Company’s previously-announced plan to remove its direct exposure to the U.S. cannabis sector in order to eliminate the increasing administrative and capital costs associated with such holdings.  Subject to the structuring of the definitive agreement, this proposed transaction would also significantly reduce dilution of shareholders of the Company by eliminating the need to issue additional shares of NORTHBUD related to the U.S. acquisitions,” said Ryan Brown, NORTHBUD’s Executive Chairman and Interim CEO.  “We look forward to the successful completion of this deal to divest our U.S. holdings, which will significantly improve the Company’s balance sheet and available cash flow, a key Company objective in light of the difficult economic climate brought on by Covid-19.”

About North Bud Farms Inc.

NORTHBUD owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada. Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution. Through its Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking Statements

Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, those regarding the timing of the Company’s filing of its year-end and quarterly financial statements, U.S. and Canadian strategies, the success of the Company’s licence application with Health Canada, the Company’s ability to close its proposed sale of BBUSA, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Datametrex $DM.ca Obtains Rights to Sell #COVID19 Tests From Two Additional South Korean Manufacturers

Posted by AGORACOM-JC at 7:32 AM on Wednesday, May 6th, 2020
  • Secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration
  • Approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices for the United States, and CE marking certification (for European Economic Area countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit

TORONTO, May 06, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell COVID-19 test kits from two additional South Korean manufacturers, including a kit that is U.S. Food & Drug Administration (“FDA”) approved under Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices (“EUA”) for the United States, and CE marking certification (“CE”) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom under Brexit.

According to each of the manufacturers, these test kits made are both Nucleic Acid based, which Health Canada is prioritizing the review of. Each of the manufacturers’ test kits have been submitted to Health Canada approval on a fast track basis and, until such approval is granted, these tests may not be sold or used in Canada. The Company is currently working closely with Health Canada to have the approval of the test kits fast tracked. An Interim Order Request for Health Canada has been submitted for 300,000 kits immediately and an additional 100,000 weekly thereafter.

One of the test kits, manufactured by Seasun Biomaterials (“Seasun”) Inc. of South Korea, was authorized on April 27, 2020 by the FDA in the United States for Emergency Use under the EUA by authorized laboratories and has also been approved for use in the EEA with CE marking certification. With regard to the FDA authorization: (1) this test has not been FDA cleared or approved; (2) this test has been authorized by the FDA only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and (3) this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Seasun claims that the average number of specimens that can be tested in a 12 hour period with their U-TOP COVID-19 Real-Time Detection Kit is 3,400. Seasun advises this is the equivalent of approximately 283 tests per hour, and the kit uses dual-labeled peptide nucleic acid probes to detect two distinct regions in ORF1ab and one region in N gene of the SARS-CoV-2 genome in oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, and sputum. The test runs on any authorized RT-PCR instrument and can be performed by any lab CLIA-certified to perform high-complexity tests.

Seasun is an in vitro diagnostic company that develops molecular diagnostic platforms of infection diseases, cancer as well as genetic and epigenetic disorders. Seasun develops and commercializes innovative real-time PCR-based diagnostic platforms through the development of its proprietary technologies to provide more advanced molecular diagnostic services. Seasun’s test kits will be distributed by its third party distributor, which Datametrex has agreements in place with for distribution globally. The other manufacturer that Datametrex has obtained sales rights from has requested not to be named publicly at this time.

The Company announced on April 21, 2020 the appointments of Dr. Joseph Curtis and Dr. Lisa Palleson-Stallan to the advisory board in anticipation of securing US FDA EUA approval on the test kits. Selling into the US market requires infrastructure and a qualified contact person that can assist not only in identifying opportunities to sell the test kits but also with the compliance requirements. The Company is continuing to work with Health Canada with respect to the application for approval of previously announced iONEBIO Inc. COVID-19 test kits.

“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA under EUA approved test kits allow us to help our neighbours to the south and any Canadian company with operations in the US and Europe,” says Marshall Gunter, CEO of the Company.

The Company’s ability to fulfill any purchase order for COVID-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, the manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

The Company did not pay consideration to either of the manufacturers to obtain sales rights. Seasun’s application to have its test approved by Health Canada were submitted directly by Seasun, while Datametrex submitted an application for approval with respect to the other manufacturer’s tests.

About CE Marking

CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA). The CE marking is also found on products sold outside the EEA that have been manufactured to EEA standards. This makes the CE marking recognizable worldwide even to people who are not familiar with the European Economic Area (the 27 member states of the EU, the 4 members of European Free Trade Association (“EFTA”), plus Turkey and United Kingdom). CE marking also supports fair competition by holding all companies accountable to the same rules. For more information please consult the European Commission website at: CE marking.

About Food and Drug Administration EUA

On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens – Advisor
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

St-Georges Announces Permits Have Been Obtained for Iceland #Gold Projects

Posted by AGORACOM-JC at 4:35 PM on Tuesday, May 5th, 2020
  • Received permits, and thus, the green light for its 2020 seasonal work programs for the Vopnafjordur and Trollaskagi gold and polymetallic licenses in Iceland
  • Icelandic mineral licensing authority, Orkustofnun, has today approved the work programs submitted by the Company

Reykjavik – May 5, 2020 St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) is pleased to announce that it has received the permits, and thus, the green light for its 2020 seasonal work programs for the Vopnafjordur and Trollaskagi gold and polymetallic licenses in Iceland.

The Company announced on April 24, 2020, that it expected to be able to do work in June and July within the licenses. The Company submitted the work programs for approval on March 31, 2020.

The Icelandic mineral licensing authority, Orkustofnun, has today approved the work programs submitted by the Company.

Covid-19 Impact Assessments

The Icelandic government has further eased its Covid-19 restrictions. The pandemic is expected to have a limited impact on the work programs scheduled to commence shortly.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur Thor Vilhjalmsson”

Vilhjalmur Thor Vilhjalmsson
President and CEO

About St-Georges

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

theScore’s #Esports Menu Expands With Live Shows – SPONSOR: Esports Entertainment Group $GMBL $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM-JC at 3:42 PM on Tuesday, May 5th, 2020

SPONSOR: Esports Entertainment Group (GMBL:NASDAQ) – Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is the next generation online gambling company designed for the purpose of facilitating as much of this wagering as possible.  LEARN MORE.

theScore’s Esports Menu Expands With Live Shows

By Danni Santana

  • The company tested its live content strategy with a charity esports event May 1.
  • theScore has set new records for Youtube views in two straight months, headlined by 28 million views in April.

Toronto-based theScore is best known for its sports news and betting apps. But it has quickly developed a strong following on YouTube for esports – surpassing 1 million subscribers last November. 

Now, the company is adding to its esports repertoire by introducing live-streamed shows and community events to gaming fans. 

theScore’s esports vertical, launched in 2015, has undergone multiple iterations, according to Aubrey Levy, who oversees esports strategy as the company’s vice president of content. What began as just providing scores and highlights of significant pro leagues and events has shifted to a focus on competitive gaming culture.

“It’s been a bit of navigation and an exploratory journey to get to the strategy that works,” Levy said. “We started by thinking we could leverage our existing sports app and apply that to esports when nobody was doing that. We did that. We marketed the hell out of it and saw some pickup, but ultimately we saw a cap on that addressable audience, which was surprising.” 

theScore now produces between eight to 10 original shows weekly for viewers, delving into crucial moments from competitions and profiling player personalities. The approach is a common one within esports circles as a means to grow the industry’s popularity with casual gamers while appeasing hardcore fans. 

Rather than adapting franchises to popular esports titles, theScore’s original shows, including “The Story Of” and “Esports Shorts,” look for story angles from competitive League of Legends or Counter-Strike: Global Offensive that directly fit its shows concepts. theScore also partners with publishers to produce one-off series that promote a tournament or a younger esports title such as Mortal Kombat or Tom Clancy’s Rainbow Six Siege.

Staff being forced to work remotely due to the coronavirus pandemic hasn’t led to a disruption in any of theScore’s programming. theScore attracted a record 23.3 million views in March, a number it later surpassed in April with 28 million views. The company attributes the rise in viewership partly to the backdrop of traditional sports being on pause. 

“I think consumers are looking for outlets, and fortunately, we’ve been able to benefit in terms of an uptick in viewership because of that,” Levy said. theScore’s April viewership totals represent a 150% year-over-year increase.

Following the success producing video-on-demand content for streaming audiences, theScore took its first crack at running a live esports event around Ubisoft’s Rainbow Six Siege on May 1.

The COVID-19 relief event, “Pros vs. Plebs,” offered fans of Rainbow Six Siege a chance to enter a one-day competition and face off against current world champions SpaceStation Gaming and former world champion and esports content creator George “KingGeorge” Kassa. 

Fans gave $5 per entry – which was donated to the Coronavirus Relief Fund part of the Global Giving’s Disaster Recovery Network. More than $8,000 was raised, according to theScore. 

The three-hour stream was broadcast on theScore’s Twitch and YouTube channels and was produced without the help of a third-party, according to the company. More than 37,000 fans have watched the event as of May 4.  

“This is an extension to live streaming from VOD, and less so about starting an events division,” Levy said. “The event just seemed like a good opportunity for us to dip our toes into the water with livestreaming.” 

theScore concedes there will be a large amount of trial and error as it introduces more live shows or community-based gaming competitions across multiple titles. To date, there is no defined or concrete content strategy for its new approach. 

However, in the leadup to the coronavirus pandemic, theScore came up with several show ideas to test, including a desk-side studio show and another focused on gameplay style.  

“Honestly, I think both live shows and events are open avenues for us,” Levy said. “We have the capacity to run these community-based events. And if they are successful I think we have the ability to continue standing those up across multiple titles. At the same time, we figure out our next live show after our charity event. I think you’ll probably see us try out both.”

Source: https://frntofficesport.com/thescore-esports-content-strategy/